Current price levels represent good timing for the opening of new short positions with respect to shares in UniCredit S.p.A.. The resistance zone around 12.81 EUR could effectively set off a correction phase over the short term. Investors should open a short trade and target the € 11.
Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
Historically, the company has been releasing figures that are above expectations.
The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
Analysts covering this company mostly recommend stock overweighting or purchase.
Stock prices approach a strong long-term resistance in weekly data at EUR 12.76.
The stock is currently in contact with a medium-term resistance that must be gotten rid of so as to resume the upward trend.
According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.